Clinical features and genetic analysis of three patients with severe hypertriglyceridaemia

Amanda Hooper, J. Kurtkoti, I.R. Hamilton-Craig, John Burnett

    Research output: Contribution to journalArticle

    9 Citations (Scopus)

    Abstract

    Hypertriglyceridaemia is a common biochemical abnormality that can be due to primary causes or, more commonly, secondary causes. Moderate hypertriglyceridaemia is a risk factor for cardiovascular disease and can develop into severe hypertriglyceridaemia which is a risk factor for acute pancreatitis. Familial chylomicronaemia is a rare autosomal recessive disorder, usually diagnosed in childhood and is characterized by marked hypertriglyceridaemia and biochemical deficiency of lipoprotein lipase (LPL), apolipoprotein (apo) C-II, homozygous (or compound heterozygous) gene mutations in LPL or more rarely, APOC2. Recently, loss-of-function mutations in the APOA5 gene have been reported in patients with severe hypertriglyceridaemia in whom LPL or APOC2 mutations were not found. We describe the clinical features and genetic analysis of three patients with severe hypertriglyceridaemia including novel mutations LPL c.464T>C (p.Leu155Pro) and APOA5 c.823C>T (p.Gln275*). © The Author(s) 2014 Reprints and permissions.
    Original languageEnglish
    Pages (from-to)485-489
    JournalAnnals of Clinical Biochemistry
    Volume51
    Issue number4
    DOIs
    Publication statusPublished - 2014

    Fingerprint Dive into the research topics of 'Clinical features and genetic analysis of three patients with severe hypertriglyceridaemia'. Together they form a unique fingerprint.

    Cite this